Client talk
Over the years we have worked with multiple clients on many exciting and diverse challenges. Our long-term clients represent our true record of success. What they say about Solubility is more important than what we say about ourselves. We welcome the opportunity to arrange a reference should you wish.
I have worked with Jeff in various of my roles over the years, and have found his advice to be sound and commercial. He has also been extremely responsive and made every effort to work in my demanding time frames. He has worked with me on international contracts, involving quite complex IP and service deals and I have no hesitation in recommending him.
Dr ELAINE SAUNDERS
Co-Founder, BlameySaundersHears
Adj Professor, Swinburne University, Professional Director
We first engaged Solubility in July 2015 at the recommendation of our key investor groups. Our primary focus at the time was to secure experienced corporate counsel in the standing up of a new Australian subsidiary. We were assigned a client liaison and worked with the firm extensively on what was to become a very successful venture. Over the last 4 years, the firm has been responsive to all of our corporate needs and matters as a Delaware C-Corp. Importantly the lawyers and associates at Solubility worked very hard to understand our technology and the mechanism of action of our drug so that they could provide practical solutions to complicated contracting issues. We cannot recommend a better partner and legal counsel for a biotechnology company doing business in Australia than Solubility.
Dr HANK SAFFERSTEIN
Former Senior Vice President, Cognition Therapeutics (USA)
Executive In Residence at UPMC Enterprises
I have instructed Solubility to act on a number of matters over the years, usually relating to licensing intellectual property and the preparation of the consequent documentation required to achieve the end result. I have always found Jeff Bergmann, in particular, highly responsive, bringing a specialist expertise to the matter, which is not easily found elsewhere. Jeff also brings sound strategic thinking to discussions in an effort to solve the inevitable commercial issues that can arise in complex licensing transactions.
PETER TURVEY
Director, Starpharma, Cell Therapies, ImmVirX and Agriculture Victoria Services
Former company secretary and general counsel, CSL, former Director, Viralytics
The professionals at Solubility offer exceptional, yet practical and pragmatic, expertise to address complex issues and create workable solutions. My experience with Solubility has been very positive, as we collaborate effectively and seamlessly to achieve the goals of our shared clients. The pragmatic approach of Solubility’s IP experts brings real solutions to projects rather than theoretical impediments.
RANDALL E. PRATT
Founder, Life Science Legal (USA)
Solubility has provided legal support for two of my companies over the past ten years. Jeff and his team are responsive, accessible, pragmatic and, importantly, flexible in accommodating the needs of small companies. I regularly recommend Solubility to companies looking for high quality but affordable legal advice.
Dr IAN NISBET
Co-Founder and Corporate Advisor, Cartherics
Former Director, planning and coordination, CSL, former Chairman, Verva
I engaged Solubility to assist our family on several in-licensing agreements for a number of patent families from Clover Corporation, CSIRO and WCHRI. Having known Jeff since the CSL float, I have found him to offer a rare combination of specialist expertise, commercial acumen and pragmatism
Dr BRIAN McNAMEE
Chairman and former CEO, CSL
Because of its reputation in the IT sphere, we contracted Solubility for our young and unique not-for-profit clinical data company (OPAL Rheumatology Australia). Solubility demonstrates a responsiveness and willingness to collaborate with us to develop contracts and strategies, which are sound and yet enable us to safely pivot and react to changing circumstances. We have been delighted with the partnership.
Dr HEDLEY GRIFFITHS
Managing Director, OPAL Rheumatology
In the world of Australian biotech IP legal advice, Jeff Bergmann and the team at Solubility is the go-to firm. They are always available, meticulous, professional and fun to work with
Dr GEOFF BROOKE
Founder, GBS Venture Partners
Solubility was excellent to deal with, responsive to our requests but independent and professional in their responses. Their specialist knowledge was particularly valuable and they handle our queries with both insight and precision. Overall a great group to work with.
DANIEL McOWAN
Executive Officer, Tapestry Foundation of Australia
I have worked with Jeff for over 20 years since our first global transactions in the mid-1990s. Jeff is a highly proficient licensing law professional with a deep understanding of the global pharma and biotech sector. Jeff is passionate about the biotech sector and I am grateful for his ongoing excellent advice and support over multiple transactions.
Dr MALCOM McCOLL
CEO and co-founder, ImmVirX
Former CEO, Viralytics, former VP Global Business Development Animal Health, CSL
Representative recent clients
Public companies
Private companies
ATMO
Aurora Spa Rituals/ASPAR
Cartherics
Earth Bottles
FE Technologies
Forms Express
Kitsunei
HealthRFID
ImmVirX
Liberty BioSecurity
Livac
MiJo Tenders
oNKo-Innate
Planet Innovation
Premneo Pharmaceuticals
Trajan Scientific
Verve Portraits
VC investee companies
Armaron/NeuProtect
Cardihab
Foundry Therapeutics
Hatchtech
Oculo
PolyActiva
Verva
Research institutes, NFPs
ANDHealth
Arts Law Centre
Asialink
Lenswood Co-op/NFGA
Melbourne Business School
National Serology Reference Laboratory
Peter MacCallum Cancer Centre
St Vincent’s Institute of Medical Research
University of Melbourne
Tapestry Foundation of Australia
Public companies
Dulux
Dimerix
IP Group
Patrys
Race Oncology
Viralytics
Private companies
ATMO
Aurora Spa Rituals/ASPAR
Cartherics
Earth Bottles
FE Technologies
Forms Express
Kitsunei
HealthRFID
+ MORE - LESSImmVirX
Liberty BioSecurity
Livac
MiJo Tenders
oNKo-Innate
Planet Innovation
Premneo Pharmaceuticals
Trajan Scientific
Verve Portraits
VC investee companies
Armaron/NeuProtect
Cardihab
Foundry Therapeutics
Hatchtech
Oculo
PolyActiva
Verva
Research institutes, NFPs
ANDHealth
Arts Law Centre
Asialink
Lenswood Co-op/NFGA
Melbourne Business School
National Serology Reference Laboratory
Peter MacCallum Cancer Centre
St Vincent’s Institute of Medical Research
University of Melbourne
Tapestry Foundation of Australia
Representative counterparties
Abbvie
AirBNB
Australian Bureau of Statistics
Australian Public Service Commission
Australian Taxation Office
BristolMyersSquibb
Bose
Celularity
Charles River Laboratories
Cornell University
CSIRO
Department of Health & Ageing
Department of Defence
Dr Reddy’s
Fresenius-Kabi
Fujifilm Corporation
Genentech
Gilead Biosciences
Griffith University
Harvard University
Hearing Lab Technology LLC
Infa-Secure
IQVIA
Janssen
John Wiley & Sons
Kite Pharma
MaynePharma
Merck
Mesoblast
Microbiotica
Novartis
NovoNordisk
Novotech
Monash University
Pfizer
QUT
Roche
Sandoz
Sonova
Specsavers
Sumitomo
Syneos Health
Thermo Fisher
ToolGen
UniQuest
University of Sydney
Victoria University
WEHI
Wisconsin Alumni Research Foundation
Xerox
Yale University
Abbvie
AirBNB
Australian Bureau of Statistics
Australian Public Service Commission
Australian Taxation Office
BristolMyersSquibb
Bose
Celularity
Charles River Laboratories
Cornell University
CSIRO
Department of Health & Ageing
Department of Defence
Dr Reddy’s
Fresenius-Kabi
Fujifilm Corporation
Genentech
Gilead Biosciences
Griffith University
Harvard University
Hearing Lab Technology LLC
Infa-Secure
IQVIA
Janssen
John Wiley & Sons
Kite Pharma
MaynePharma
Merck
Mesoblast
Microbiotica
Novartis
NovoNordisk
Novotech
Monash University
Pfizer
QUT
Roche
Sandoz
Sonova
Specsavers
Sumitomo
Syneos Health
Thermo Fisher
ToolGen
UniQuest
University of Sydney
Victoria University
WEHI
Wisconsin Alumni Research Foundation
Xerox
Yale University
Representative industries
Alzheimer’s’ therapy
Ballistic-proof sunglasses
Blood typing reagents
Bottles
Bottle openers
Breast cancer and metastasis
CAR-T therapy
Corporate governance training programmes
Course materials
Data analysis
Defence
Digital health incubator
Faecal microbial transplant technology
Government vaccine procurement
Hearing aids
Heart pump device
Lice treatments
Liver retractor device
Mesenchymal Stem Cell technology
Modular programable blocks
Ophthalmology
Pain medicaments
Photography
Premature infant treatments
Professional referral platform software
RFID technology
Spa products
Tapestry commissioning
Tech transfer
Tourist Apps
Vaccine egg supply
Venture capital
Alzheimer’s’ therapy
Ballistic-proof sunglasses
Blood typing reagents
Bottles
Bottle openers
Breast cancer and metastasis
CAR-T therapy
Corporate governance training programmes
Course materials
Data analysis
Defence
Digital health incubator
Faecal microbial transplant technology
Government vaccine procurement
Hearing aids
Heart pump device
Lice treatments
Liver retractor device
Mesenchymal Stem Cell technology
Modular programable blocks
Ophthalmology
Pain medicaments
Photography
Premature infant treatments
Professional referral platform software
RFID technology
Spa products
Tapestry commissioning
Tech transfer
Tourist Apps
Vaccine egg supply
Venture capital